The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk. - Xu, Chang; Gao, Xudong; Ren, Tianshu; Geng, Hefeng; Yang, Kaisi; Huang, Yaoguang; Zhang, Weige; Hou, Shanbo; Song, Aigang; Zhang, Yingshi; Zhao, Qingchun (Pharmacological Research, 2024)